Emily Sullivan - January 22, 2025 Pharma trade marks: 2024 EU case law round up The pharmaceutical industry continues to face evolving challenges in trade mark law. 2024 brought ...
Andy King - November 27, 2024 Bad Faith or Business Strategy? Sky vs. SkyKick Sets a Precedent The long running saga of the battle between Sky Ltd (“Sky”) and SkyKick UK Ltd (“SkyKick”) is ...
Emily Sullivan - August 14, 2024 Cipla Europe NV v Glaxo Group Ltd: can a 3D trade mark be distinctive? Trade mark proceedings can often feel like never-ending stories. In this case, Glaxo Group Ltd. ...
Emily Sullivan - January 9, 2024 Pharma trade marks: 2023 EU case law round up As we enter 2024, we reflect on the lessons we have learned in 2023. The trade mark landscape has ...
Emily Sullivan - August 31, 2023 Understanding parallel import of pharmaceuticals in the EU – a quick guide to repackaging and relabelling of parallel imports for brand owners Parallel importing, the practice where third parties import branded goods already put on sale by ...
Emily Sullivan - June 2, 2023 EUIPO vs “EMMENTALER” Trade mark courts worldwide spend a good deal of time deciding what trade marks cheese ...
Emily Sullivan - March 24, 2023 Spot the difference: where UK and German laws go astray Despite the harmonisation of trade mark law in Europe over the past decades, significant ...
Emily Sullivan - February 28, 2022 Protecting film, music and game titles in Germany - 10 key questions answered Time and again, clients from the media, entertainment and, in particular, gaming sector approach us ...
Emily Sullivan - August 10, 2020 Is Sky the limit in the David versus Goliath trade mark battle of the last decade? Hilda-Georgina Kwafo-Akoto examines the potential implications of Sky v Skykick.
Emily Sullivan - April 22, 2020 The CJEU delivers the sweet fragrance of victory to Amazon On 2 April 2020 the Court of Justice of the European Union (CJEU) delivered its preliminary ruling ...
